PET/CT in radiation oncology

R Fonti, M Conson, S Del Vecchio - Seminars in oncology, 2019 - Elsevier
The progressive integration of positron emission tomography/computed tomography
(PET/CT) imaging in radiation therapy has its rationale in the biological intertumoral and …

Recent advances in radiation therapy and photodynamic therapy

LM Chong, DJH Tng, LLY Tan, MLK Chua… - Applied Physics …, 2021 - pubs.aip.org
In the past 100 years, external beam energy for the treatment of cancer has continually
evolved. Two main modes have been developed. The first is radiotherapy which involves …

Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

J Calais, J Czernin, WP Fendler, D Elashoff… - BMC cancer, 2019 - Springer
Background Salvage radiotherapy (SRT) for prostate cancer (PCa) recurrence after
prostatectomy offers long-term biochemical control in about 50–60% of patients. SRT is …

Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer

J Calais, AU Kishan, M Cao… - Journal of Nuclear …, 2018 - jnm.snmjournals.org
Standard-of-care imaging for initial staging of prostate cancer (PCa) underestimates disease
burden. Prostate-specific membrane antigen (PSMA) PET/CT detects PCa metastasis with …

Salvage therapy for prostate cancer after radical prostatectomy

NG Zaorsky, J Calais, S Fanti, D Tilki, T Dorff… - Nature Reviews …, 2021 - nature.com
More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

68Ga-PSMA-11 PET/CT in primary and recurrent prostate carcinoma: implications for radiotherapeutic management in 121 patients

SA Koerber, L Will, C Kratochwil… - Journal of Nuclear …, 2019 - jnm.snmjournals.org
The present study analyzed the impact of 68Ga-labeled prostate-specific membrane antigen-
HBED-CC (68Ga-PSMA-11) PET/CT on radiotherapeutic management in a large cohort of …

Update from PSMA-SRT trial NCT03582774: a randomized phase 3 imaging trial of prostate-specific membrane antigen positron emission tomography for salvage …

J Calais, WR Armstrong… - European …, 2021 - eu-focus.europeanurology.com
Salvage radiation therapy (SRT) for prostate cancer (PCa) recurrence after radical
prostatectomy (RP) can offer longterm biochemical control in approximately 50–60% of …

The use of quantitative imaging in radiation oncology: a quantitative imaging network (QIN) perspective

RH Press, HKG Shu, H Shim, JM Mountz… - International Journal of …, 2018 - Elsevier
Modern radiation therapy is delivered with great precision, in part by relying on high-
resolution multidimensional anatomic imaging to define targets in space and time. The …

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] …

J Calais, S Zhu, N Hirmas, M Eiber, B Hadaschik… - BMC cancer, 2021 - Springer
Background Definitive radiation therapy (dRT) is an effective initial treatment of intermediate-
risk (IR) and high-risk (HR) prostate cancer (PCa). PSMA PET/CT is superior to standard of …